Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES)

Nav

General Info

Geography

Germany (DEU)

Time period covered

01/1998 - 12/2002

Data type

Scientific literature

Keywords

Ischemic stroke

Citation

Authors

Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC, MOSES Study Group

Journal

Stroke

Volume

Issue

Pages

1218–26

Publication year

2005

Suggested citation

Schrader J, Lüders S, Kulschewski A, Hammersen F, Plate K, Berger J, Zidek W, Dominiak P, Diener HC, MOSES Study Group. Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES). Stroke. 2005; 36(6): 1218–26.

GHDx Entry last modified on: Sep 3, 2019

Header sites

Search form

Main menu

Morbidity and Mortality After Stroke, Eprosartan Compared with Nitrendipine for Secondary Prevention: principal results of a prospective randomized controlled study (MOSES)

Nav